semaglutide 25 Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) and reduced What to Know About Semaglutide:

Get in touch with our team to start a conversation.

Understanding how long GLP-1 approaches take to start working helps set realistic expectations for any method you choose

What happens when you stop each medication Weight regain after stopping weight loss medications is a reality for both classes, but the dynamics differ

Extended stability testing at 5, 25, 40, 60, and 80 degrees Celsius revealed that while semaglutide remained stable for 3 hours even at 80 degrees Celsius under stress conditions, real-world storage demands consistent cold temperatures for long-term stability

Some weight loss clinics, pharmacies, and other companies claim to have availability of compounded semaglutide products, including products that purport to offer semaglutide in combination with other ingredients, a Novo Nordisk spokesperson explains